KemPharm Inc. | Ownership

Companies that own KemPharm Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
DSC Advisors LP
2,095,914
13.07%
304,283
4.5%
07/30/2018
Alyeska Investment Group LP
883,681
5.51%
-8,897
0.04%
06/30/2018
Arete Wealth Advisors LLC
515,112
3.21%
-45,870
0.61%
06/30/2018
Creative Planning, Inc.
451,814
2.82%
-1,709
0.01%
06/30/2018
The Vanguard Group, Inc.
435,735
2.72%
26,408
0%
06/30/2018
C WorldWide Asset Management Fondsmæglerselskab A/S
399,999
2.49%
12,319
0.02%
06/30/2018
Cowen Investment Management LLC
366,313
2.27%
366,313
0.81%
06/30/2018
Renaissance Technologies LLC
181,800
1.12%
91,400
0%
06/30/2018
Victory Capital Management, Inc.
170,667
1.06%
-9,070
0%
06/30/2018
Millennium Management LLC
151,250
0.94%
135,784
0%
06/30/2018

About KemPharm

View Profile
Address
1180 Celebration Boulevard
Celebration Florida 34747
United States
Employees -
Website http://www.kempharm.com
Updated 07/08/2019
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M.